Evidence map›Paper›PMID 41283949›Full record

ArticleDiscover oncology2025

Development and explanation of a machine learning model for identifying non-localized early-onset T1 colorectal cancer.

Yin Zhang, Fuzhou Han, Mingyu Zheng, Duo Xu, Nan Yao, Wenqiang Li, Jun Qu

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yin Zhang *Department of General Surgery, Aerospace Center Hospital, Beijing, China.
Fuzhou Han *Department of General Surgery, Aerospace Center Hospital, Beijing, China.
Mingyu Zheng *Department of General Surgery, Aerospace Center Hospital, Beijing, China.
Duo XuDepartment of General Surgery, Aerospace Center Hospital, Beijing, China.
Nan YaoDepartment of General Surgery, Aerospace Center Hospital, Beijing, China.
Wenqiang LiDepartment of General Surgery, Aerospace Center Hospital, Beijing, China. liwen821216@163.com.
Jun QuDepartment of General Surgery, Aerospace Center Hospital, Beijing, China. qujunchief@163.com.

Funding

the Science Foundation of AMHT 2021YK13the Science Foundation of AMHT 2022YK05
6 · The paper itself

Abstract

backgroundFor patients with early-onset T1 colorectal cancer (CRC), it is crucial to perform radical resection with minimal tissue damage. This study aims to develop and elucidate a machine learning model for the identification of non-located early-onset T1 CRC.

methodsWe extracted relevant data from the Surveillance, Epidemiology, and End Results (SEER) database and randomly allocated patients into a training set and a validation set. Five machine learning models were utilized: extreme gradient boosting (XGBoost), support vector machine (SVM), random forest (RF), decision tree (DT), and logistic regression (LR) were developed for the tumor metastasis status prediction. Area under the receiver operating characteristic curve (AUC) and confusion matrix were used to evaluate the model. The Shapley Additive Explanations (SHAP) method was employed as the primary technique for model explanation.

resultsA cohort of 1,878 patients was selected according to predefined inclusion and exclusion criteria. The XGBoost model was selected for its favorable performance, with an AUC of 0.755 and accuracy of 0.833 in the validation cohort. Significant risk factors, identified by SHAP values greater than 0.1 for non-localized T1 tumors, included carcinoembryonic antigen (CEA) levels exceeding 5 ng/mL, tumor size greater than 5 cm, mucinous adenocarcinoma, signet-ring cell adenocarcinoma, tumor location in the left colon, and poorly differentiated or undifferentiated histological grades. Additionally, black race, a diagnostic-to-surgical interval exceeding one month and PNI may represent potential risk factors.

conclusionThe XGBoost model holds the potential to assist clinicians in evaluating and selecting optimal treatment strategies for patients with early-onset T1 CRC.

Indexed as

Distant metastasisEarly-onset colorectal cancerLymph node metastasisMachine learningT1 stage colorectal cancer

Identifiers

PMID41283949
PMCPMC12644358

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.